Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Neutrophil hyperchemotaxis in Behçet s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses (2009)

  • Authors:
  • USP affiliated authors: MELLO, SUZANA BEATRIZ VERISSIMO DE - FM ; CARRASCO, SOLANGE - FM
  • USP Schools: FM; FM
  • DOI: 10.1007/s10067-009-1261-5
  • Subjects: AUTOIMUNIDADE; QUIMIOTAXIA; MONÓCITOS; NEUTRÓFILOS; INFLAMAÇÃO
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10067-009-1261-5 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Clinical Rheumatology

    ISSN: 0770-3198

    Citescore - 2017: 2.04

    SJR - 2017: 0.93

    SNIP - 2017: 0.877


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM1825879-10BCBIB
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      NEVES, Fabrício Souza; CARRASCO, Solange; GOLDSTEIN-SCHAINBERG, Cláudia; GONÇALVES, Célio Roberto; MELLO, Suzana Beatriz Veríssimo. Neutrophil hyperchemotaxis in Behçet s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses. Clinical Rheumatology, Brussels, v. 28, n. 12, p. 1403-1410, 2009. Disponível em: < http://www.springerlink.com/content/x408073475002843/fulltext.pdf > DOI: 10.1007/s10067-009-1261-5.
    • APA

      Neves, F. S., Carrasco, S., Goldstein-Schainberg, C., Gonçalves, C. R., & Mello, S. B. V. (2009). Neutrophil hyperchemotaxis in Behçet s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses. Clinical Rheumatology, 28( 12), 1403-1410. doi:10.1007/s10067-009-1261-5
    • NLM

      Neves FS, Carrasco S, Goldstein-Schainberg C, Gonçalves CR, Mello SBV. Neutrophil hyperchemotaxis in Behçet s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses [Internet]. Clinical Rheumatology. 2009 ; 28( 12): 1403-1410.Available from: http://www.springerlink.com/content/x408073475002843/fulltext.pdf
    • Vancouver

      Neves FS, Carrasco S, Goldstein-Schainberg C, Gonçalves CR, Mello SBV. Neutrophil hyperchemotaxis in Behçet s disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses [Internet]. Clinical Rheumatology. 2009 ; 28( 12): 1403-1410.Available from: http://www.springerlink.com/content/x408073475002843/fulltext.pdf

    Referências citadas na obra
    Yurdakul S, Hamuryudan V, Yazici H (2004) Behçet syndrome. Curr Opin Rheumatol 16:38–42
    Direskeneli H (2006) Autoimmunity vs autoinflammation in Behçet’s disease: do we oversimplify a complex disorder? Rheumatology 45:1461–1465
    Matsumara N, Mizushima Y (1975) Leucocyte movement and colchicine treatment in Behçet’s disease. Lancet 2:813
    Carletto A, Pacor ML, Biasi D et al (1997) Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet’s disease. J Rheumatol 24:1332–1336
    Tüzün B, Tüzün Y, Yurdakul S, Hamuryudan V, Yazici H, Ozyazgan Y (1999) Neutrophil chemotaxis in Behçet’s syndrome. Ann Rheum Dis 58:658
    The Behçet’s Disease Research Committee of Japan (1989) Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet’s disease—a multicenter study. J Rheumatol 16:506–511
    Lehner T (1999) Immunopathogenesis of Behçet’s disease. Ann Med Interne (Paris) 150:483–487
    Direskeneli H, Eksioglu-Demiralp E, Yavuz S et al (2000) T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet’s disease. J Rheumatol 27:708–713
    Calguneri M, Kiraz S, Ertenli I, Benekli M, Karaarslan Y, Celik I (1996) The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet’s disease. Arthritis Rheum 39:2062–2065
    Niwa Y, Mizushima Y (1990) Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increased in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet’s disease. Clin Exp Immunol 79:353–360
    Medzhitov R, Hurlburt-Preston P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signs activation of adaptive immunity. Nature 388:394–397
    Roelofs MF, Abdollahi-Roodsaz S, Joosten LAB, van den Berg WB, Radstake TRDJ (2008) The orchestra of Toll-like receptor and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 58:338–348
    Lotz S, Aga E, Wilde I et al (2004) Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J Leuk Biol 75:467–477
    Schröder NWJ, Morath S, Alexander C et al (2003) Lipoteichoic Acid (LTA) of streptococcus pneumoniae and staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lypopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278:15587–15594
    Kurt-Jones EA, Mandell L, Whitney C et al (2002) Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR-2 mediated interleukin 8 responses in neutrophils. Blood 100:1860–1868
    Do JE, Kwon SY, Park S, Lee ES (2008) Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet’s disease. Rheumatology 47:840–848
    Kirino Y, Takeno M, Watanabe R et al (2008) Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet’s disease. Arthritis Res Ther 10:R16
    Nara K, Kurokawa MS, Chiba S et al (2008) Involvement of innate immunity in the pathogenesis of intestinal Behçet’s disease. Clin Exp Immunol 152:245–251
    Yavuz S, Elbir Y, Tulunay A, Eksioglu-Demiralp E, Direskeneli H (2008) Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behçet’s disease etiopathogenesis. Rheumatol Int 28:401–406
    Sabroe I, Prince LR, Jones EC et al (2003) Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 170:5268–5275
    Sabroe I, Jones EC, Whyte MKB, Dower SK (2005) Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4. Immunology 115:90–98
    Aomatsu K, Kato T, Fujita H et al (2007) Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases. Immunology 123:171–180
    Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acute-phase protein. J Immunol 172:4470–4479
    International Study Group for Behçet’s Disease (1991) Criteria for diagnosis of Behçet’s Disease. Lancet 335:1078–1080
    Neves FS, Moraes JCB, Kowalski SC, Goldenstein-Schainberg C, Lage LV, Gonçalves CR (2007) Cross-cultural adaptation of the Behçet’s Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 26:1263–1267
    Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38:728–733
    Mumcu G, Inanc N, Yavuz S, Direskeneli H (2007) The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet’s disease. Clin Exp Rheumatol 25(4 Suppl 45):S27–S33
    Tunc R, Keyman E, Melikoglu M et al (2002) Target organ associations in Turkish patients with Behçet’s disease: a cross sectional study by exploratory factor analysis. J Rheumatol 29:2393–2396
    Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H (2001) Papulopustular skin lesions are seen more frequently in patients with Behçet’s syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60:1074–1076
    Sobel JD, Haim S, Obedeanu N, Meshulam T, Merzbach D (1977) Polymorphonuclear leukocyte function in Behçet’s disease. J Clin Pathol 30:250–253
    Kurihara A, Ojima F, Tsurufuji S (1984) Analysis of the effect of an anti-inflammatory steroid, dexamethasone, on neutrophil chemotaxis in the Boyden chamber with a modified 51Cr-labeling method. J Pharmacobiodyn 7:747–754
    Mege JL, Dilsen N, Sanguedolce V et al (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increase neutrophil superoxide generation in Behçet’s disease. A comparative study with familial Mediterranen fever and healthy subjects. J Rheumatol 20:1544–1549
    Cuchacovich M, Merino G, Yamamoto JH et al (2005) Behçet’s disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation. Clin Exp Rheumatol 23(4 Suppl.38):S27–S34
    Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T (1996) Monocyte activity in Behçet’s disease. Br J Rheumatol 35:424–429
    Maliszewski CR (1991) CD14 and immune response to lipopolysaccharide. Science 252:1321–1322
    Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 90:2744–2748
    Troelstra A, Giepmans BN, Van Kessel KP, Lichenstein HS, Verhoef J, Van Strijp JA (1997) Dual effects of soluble CD14 on LPS priming of neutrophils. J Leukoc Biol 61:173–178
    Soler-Rodriguez AM, Zhang H, Lichenstein HS et al (2000) Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14. J Immunol 164:2674–2683